From digital tracking apps to long-lasting implants, today’s contraceptive landscape offers women unprecedented control over their reproductive health. Birth control does far more than prevent ...

Approximately 19 million U.S. women of childbearing age reside in what are known as “contraceptive deserts” due to geographic, political, economic and social barriers to birth control. Women living in ...

The first large-scale U.S.-based study to evaluate the link between an injectable form of progestin-only birth control and breast cancer risk in young women has found that recent use of a year or more ...

When it comes to their sexual health, what women don’t know can hurt them. But University Health Center officials are trying to help women improve their health by educating them about birth control ...

According to the Centers for Disease Control and Prevention (CDC), as of 2017, 65.3% of women between the ages of 15 and 49 in the United States use a form of birth control. Of this population, 10.4% ...

A popular injectable birth control, Depo-Provera (medroxyprogesterone acetate) — also sold as Depo-SubQ Provera 104 — has long been favored for its 99% effectiveness and ease of use compared to daily ...

The Singleton Schreiber Law Firm is seeking individuals who developed potentially life-altering brain tumors as a result of using a popular birth control injection. Singleton Schreiber says the ...

U.S. District Judge M. Casey Rodgers of the Northern District of Florida is overseeing more than 400 lawsuits alleging that Depo-Provera, an injectable birth control, has caused non-malignant brain ...

Contraline, a biotech company, has received regulatory approval to move onto Phase 2 of human clinical trials for a male contraceptive that conveniently blocks sperm for up to two years. Contraline ...

The judge appointed Chris Seeger as lead counsel and co-leads Ellen Relkin and Bryan Aylstock. More than 70 lawsuits against Pfizer allege Depo-Provera, an injectable birth control, has been linked to ...